Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
  1. 4 Open-market sale Former Director sold 7,047 shares at $1.31 ($9,260)
  2. 4 Open-market sale President & CEO sold 3,000 shares at $1.31 ($3,930)
  3. 8-K Event Executive or director change
  4. 424B3 Offering Prospectus
  5. 424B3 Offering Prospectus
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 424B4 Offering Prospectus
  9. EFFECT Other Notice of Effectiveness
  10. UPLOAD Other SEC-generated Letter
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. S-1 Offering Registration Statement
  13. SC 13G Stake Amended Statement of Ownership
  14. 8-K Event Material agreement · Unregistered share sale · Other events
  15. 8-K Event Other events
  16. 8-K Event Other events
  17. 8-K Event Material agreement · Other events
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. 424B4 Offering Prospectus

Page 24 of 38 · 753 filings